Home > Boards > US Listed > Biotechs > Regeneron Pharmaceuticals (REGN)

I’m in for earnings next week

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
T695 Member Profile
 
Followed By 50
Posts 3,665
Boards Moderated 0
Alias Born 05/18/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 4/7/2020 6:46:48 AM
Correction to Sanofi Article Dow Jones News - 4/7/2020 4:27:00 AM
Sanofi Finalizes Praulent Restructuring With Regeneron Dow Jones News - 4/7/2020 2:09:00 AM
Regeneron Finalizes Praluent Agreement Restructuring Dow Jones News - 4/6/2020 7:42:00 PM
Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation PR Newswire (US) - 4/6/2020 5:00:00 PM
Inside the Race to Find a Coronavirus Cure Dow Jones News - 4/6/2020 12:41:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:51:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:50:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:09:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:06:31 PM
Sanofi CEO: 'The One-Meeting Trip Will Disappear' Dow Jones News - 4/3/2020 9:29:00 AM
Recession Blue-Chips' Led the Way in Another Turbulent Week in Markets Dow Jones News - 4/3/2020 7:29:00 AM
Dupixent® (dupilumab) Phase 3 Data at Revolutionizing Atopic Dermatitis Conference Show Significant Improvement in Severe At... PR Newswire (US) - 4/3/2020 12:59:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2020 6:50:29 PM
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Sever... PR Newswire (US) - 3/30/2020 11:46:00 AM
First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19 PR Newswire (US) - 3/30/2020 12:59:00 AM
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program PR Newswire (US) - 3/17/2020 7:00:00 AM
Regeneron and Sanofi Start U.S. Studies Assessing Arthritis Drug As Coronavirus Treatment Dow Jones News - 3/16/2020 11:10:00 AM
Regeneron, Sanofi Start Trials for Drug to Treat Covid-19 Dow Jones News - 3/16/2020 8:57:00 AM
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19 PR Newswire (US) - 3/16/2020 8:09:00 AM
Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19 PR Newswire (US) - 3/16/2020 8:00:00 AM
It's a Tough Time to Be in the C-Suite, Good Time to Be in a Gas Field Dow Jones News - 3/13/2020 7:29:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 5:00:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 4:07:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 4:06:26 PM
T695   Saturday, 02/03/18 12:50:12 PM
Re: None
Post # of 141 
I’m in for earnings next week

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist